📰 Patrick Trojer News
Patrick Trojer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Patrick Trojer. Real-time updates on events, politics, business and more.
September 18, 2023
TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmaceutical company focused on advancing a target-first and rational molecular glue discovery platform to address difficult to drug disease targets, today announced that Dr. Patrick Trojer, President and Chief Executive Officer, will present at the UBS Biotechnology Private Company Virtual Symposium on Wednesday September 20, 2023 at 3:30 PM ET.
September 18, 2023
The stock price of UBS Group AG (NYSE: UBS) has plunged by -0.08 when compared to previous closing price of 26.02, but the company has seen a 1.48% gain in its stock price over the last five trading sessions. Accesswire reported 2023-09-18 that LEXINGTON, MA / ACCESSWIRE / September 18, 2023 / TRIAN
January 4, 2023
BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.
June 23, 2022
Robert A. Copeland, PhD and Adrian M. Senderowicz, MD join Scientific Advisory BoardWALTHAM, MA / ACCESSWIRE / June 23, 2022 / TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused
June 23, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
June 23, 2022
23.06.2022 - Robert A. Copeland, PhD and Adrian M. Senderowicz, MD join Scientific Advisory BoardWALTHAM, MA / ACCESSWIRE / June 23, 2022 / TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused on building a target-first and rational ... Seite 1
April 9, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
May 11, 2021
Operator Good day, and thank you for standing by, and welcome to the Constellation Pharmaceuticals First Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Kia Khaleghpour, Vice President of Investor Relations and Communications. Please go ahead. Kia Khalaghpour -- Vice President, Investor Relations and Communications Thank you, operator. Good morning, everyone, and welcome to this conference call to discuss Conste...
February 25, 2021
Operator Ladies and gentlemen, thank you for standing by and welcome to the Constellation Pharmaceuticals Fourth Quarter 2020 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference to your speaker today, Kia Khaleghpour, Vice President of Investor Relations and Communications. Please go ahead, maam. Kia Khalaghpour -- Thank you, operator. Welcome to this conference call to discuss Constellations fourth quarter 2020 financial results and operational performanc...